LataMed AI Eyes Global Growth with Plans to Explore New Healthcare Partnerships at World Health Expo 2027

Company Plans to Explore International Healthcare Opportunities

On 13th July 2026, LataMed AI Corp., a digital health and artificial intelligence company, started preparing for its planned participation at the World Health Expo 2027 in Dubai. The company sees the event as an opportunity to explore international markets beyond its current operations in Latin America. By attending the global healthcare gathering, LataMed AI hopes to connect with healthcare providers, technology companies, government officials, investors, and industry experts from different countries. These discussions are expected to help the company understand changing healthcare needs, identify new business opportunities, and evaluate possible collaborations. Although participation is still in the planning stage, the company believes the event could play an important role in shaping its long-term international growth strategy and expanding its digital healthcare solutions into new regions.

Focus on Expanding Digital Health and AI Solutions

LataMed AI is developing a broad digital healthcare ecosystem that combines telehealth services, healthcare coordination tools, pharmacy integration, insurance accessibility, payment technologies, healthcare analytics, and artificial intelligence. The company plans to use the World Health Expo as a platform to assess how these solutions can meet the needs of healthcare systems in different countries. Management believes the event will provide valuable insights into global trends such as digital health, precision medicine, AI-powered healthcare, and connected care systems. It also hopes to explore licensing opportunities and strategic partnerships that could support the future commercialization of its technologies. By learning from global healthcare leaders and technology innovators, the company aims to strengthen its products while preparing for future expansion into international markets.

Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “As we continue executing our long-term vision of building an integrated digital healthcare ecosystem, we believe it is important to evaluate opportunities beyond our existing markets. World Health Expo 2027 is expected to provide an outstanding opportunity to engage with healthcare leaders from around the world, better understand evolving global healthcare trends, and explore potential strategic relationships that may support the continued development and international expansion of the LataMed AI platform.”

Building on Existing Expansion Efforts

The planned visit to Dubai follows LataMed AI's recent efforts to increase its international presence. The company has already participated in healthcare events such as HLTH Europe while continuing to strengthen its activities across Latin America. Recent strategic initiatives in Venezuela and the evaluation of expansion opportunities in Colombia reflect its broader goal of bringing digital healthcare technologies to emerging markets. According to Chief Executive Officer Dr. Kevin Rodan Levy, exploring opportunities outside the company's existing markets is an important step in building an integrated healthcare platform. He believes international events like the World Health Expo offer valuable opportunities to understand industry developments, meet potential partners, and evaluate collaborations that may support the company's future growth. However, management also clarified that no agreements or partnerships have been finalized, and participation remains part of an ongoing evaluation process.

Company Continues Preparing for Future Growth

Alongside its international expansion plans, LataMed AI announced that its previously approved five-for-one forward stock split and mandatory share exchange are expected to take effect on July 15, 2026, after completing the required administrative procedures. The company stated that shareholders holding shares electronically are not expected to take any action, while those with physical share certificates will need to complete the exchange process through the transfer agent. LataMed AI also remains focused on advancing its telemedicine platform and commercializing its artificial intelligence solutions, including CardioAI, PulmoAI, and NeuroAI.

While management remains optimistic about future opportunities, it emphasized that many of its plans, including international expansion, partnerships, licensing agreements, and commercialization activities, remain forward-looking and depend on future business, regulatory, financial, and market conditions. The company said it will continue evaluating these opportunities carefully as it works toward its long-term vision of expanding digital healthcare services globally.

How This Could Benefit the Healthcare Industry?

LataMed AI's expansion efforts could create several positive opportunities for the broader healthcare industry. As digital health technologies become increasingly important, collaborations between technology companies, healthcare providers, insurers, and governments can improve the delivery of medical services. If the company establishes new partnerships, its telehealth infrastructure and AI-powered platforms could help improve healthcare access in regions where medical resources are limited. Better care coordination, digital patient management, pharmacy connectivity, and healthcare analytics can support faster clinical decisions and improve patient experiences.

Artificial intelligence tools designed for cardiology, pulmonology, and neurology may also help healthcare professionals analyze medical information more efficiently and support earlier disease detection. The company's focus on payment accessibility and insurance integration could make healthcare services easier to access for more patients. International collaborations may also encourage knowledge sharing, technology transfer, and the adoption of modern healthcare solutions across different countries. As healthcare systems continue to invest in digital transformation, companies developing scalable and connected technologies can contribute to a stronger healthcare infrastructure, improved operational efficiency, and better patient outcomes. These efforts also support the growing demand for integrated healthcare platforms that connect patients, providers, insurers, pharmacies, and emergency services within a single digital ecosystem.